Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Genetic Screening in Two Iranian Families With Early-Onset Alzheimer's Disease Identified a Novel Psen1 Mutation Publisher Pubmed



Wang JC1, 2, 3 ; Alinaghi S4 ; Tafakhori A5 ; Sikora E1 ; Azcona LJ1, 6 ; Karkheiran S7 ; Goate A1, 2, 3, 6, 8 ; Paisanruiz C2, 3, 6, 8, 9, 10 ; Darvish H4
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY, United States
  2. 2. Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States
  3. 3. Ronald M. Loeb Center for Alzheimer's disease, Icahn School of Medicine at Mount Sinai, New York, NY, United States
  4. 4. Department of Medical Genetics, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  5. 5. Department of Neurology, School of Medicine, Imam Khomeini Hospital and Iranian Center of Neurological Research, Tehran University of Medical Sciences, Tehran, Iran
  6. 6. Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, United States
  7. 7. Movement Disorders Clinic, Hazrat Rasool Hospital, Iran University of Medical Sciences, Tehran, Iran
  8. 8. Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, United States
  9. 9. Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, United States
  10. 10. Mindich Child Health and Development Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States

Source: Neurobiology of Aging Published:2018


Abstract

A subset of early-onset Alzheimer's disease is inherited as an autosomal-dominant trait and is associated with mutations in the genes encoding β-amyloid precursor protein, presenilin 1, or presenilin 2. In this study, we identified 2 PSEN1 mutations (1 novel and 1 known) in 2 unrelated Iranian families with autosomal-dominant Alzheimer's disease. The disease progressed rapidly with a mean age at onset of 33 and 42 years and an age at death ranging from 43 to 48 years. © 2017 Elsevier Inc.